These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 2153010)

  • 1. The use of state-of-the-art mammography in the detection of nonpalpable breast carcinoma.
    Kaplan C; Matallana R; Wallack MK
    Am Surg; 1990 Jan; 56(1):40-2. PubMed ID: 2153010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The early detection of nonpalpable breast carcinoma with needle localization. Experience with 500 patients in a community hospital.
    Miller RS; Adelman RW; Espinosa MH; Dorman SA; Smith DH
    Am Surg; 1992 Mar; 58(3):193-8. PubMed ID: 1313665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammographic and histopathologic correlation of nonpalpable lesions of the breast and the reliability of frozen section diagnosis.
    Tinnemans JG; Wobbes T; Holland R; Hendriks JH; van der Sluis RF; Lubbers EJ; de Boer HH
    Surg Gynecol Obstet; 1987 Dec; 165(6):523-9. PubMed ID: 2825366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammographic wire localization in diagnosis and treatment of occult carcinoma of breast.
    Petrovich JA; Ross DS; Sullivan JW; Lake TP
    Surg Gynecol Obstet; 1989 Mar; 168(3):239-43. PubMed ID: 2537536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The use of echography and US-guided percutaneous puncture in addition to mammography for the detection of malignant breast tumors].
    Matricardi L; Lovati R; Nazzaro V; Guarneri A; Calzoni G; Gagliano E; Donato F
    Radiol Med; 1992 Apr; 83(4):395-401. PubMed ID: 1318561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occult lesions of the breast.
    Poole GV; Choplin RH; Sterchi JM; Leinbach LB; Myers RT
    Surg Gynecol Obstet; 1986 Aug; 163(2):107-10. PubMed ID: 3016925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology.
    Monti S; Galimberti V; Trifiro G; De Cicco C; Peradze N; Brenelli F; Fernandez-Rodriguez J; Rotmensz N; Latronico A; Berrettini A; Mauri M; Machado L; Luini A; Paganelli G
    Ann Surg Oncol; 2007 Oct; 14(10):2928-31. PubMed ID: 17674108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammographic wire-guided biopsies in non-palpable breast lesions.
    Adler OB; Engel A
    Eur J Radiol; 1989 May; 9(2):108-11. PubMed ID: 2545445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The non-palpable, radiographically suspicious breast lesion: an analysis of 101 cases.
    Perre CI; Hoynck van Papendrecht AA; Sierink HD; Muller JW
    Neth J Surg; 1990 Jun; 42(3):69-71. PubMed ID: 2164172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mammography and ultrasound in the diagnosis of clinically occult breast cancer].
    Gyr T; Almendral AC; Meier D
    Gynakol Rundsch; 1989; 29(2):65-8. PubMed ID: 2544492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass screening for breast disease. Results, problems, and expectations.
    Schwartz GF; Feig SA; Libshitz HI; Patchefsky AS; Nerlinger RE; Wallace JD
    Obstet Gynecol; 1976 Aug; 48(2):137-41. PubMed ID: 181701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions.
    Bibbo M; Scheiber M; Cajulis R; Keebler CM; Wied GL; Dowlatshahi K
    Acta Cytol; 1988; 32(2):193-201. PubMed ID: 2831687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
    Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
    Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of the results of mammographically guided biopsies of the breast.
    McCreery BR; Frankl G; Frost DB
    Surg Gynecol Obstet; 1991 Mar; 172(3):223-6. PubMed ID: 1847244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with fine-wire localization breast biopsies for nonpalpable breast lesions detected mammographically.
    Luoma AA; Scudamore CH; Longley JD
    Can J Surg; 1986 Sep; 29(5):315-8. PubMed ID: 3790211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-year survival of 100 women with carcinoma of the breast diagnosed by screening mammography and needle-localization biopsy.
    Bauer TL; Pandelidis SM; Rhoads JE
    J Am Coll Surg; 1994 May; 178(5):427-30. PubMed ID: 8167877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ carcinomas of the breast. Types, growth pattern, diagnosis, and treatment.
    Andersen J; Blichert-Toft M; Dyreborg U
    Eur J Surg Oncol; 1987 Apr; 13(2):105-11. PubMed ID: 3030823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonpalpable versus palpable invasive breast tumors treated with breast-conserving surgical management.
    Tafra L; Essner R; Brenner RJ; Giuliano AE
    Am Surg; 1996 May; 62(5):395-9. PubMed ID: 8615571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
    Meijnen P; Oldenburg HS; Loo CE; Nieweg OE; Peterse JL; Rutgers EJ
    Br J Surg; 2007 Aug; 94(8):952-6. PubMed ID: 17440955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia.
    Port ER; Park A; Borgen PI; Morris E; Montgomery LL
    Ann Surg Oncol; 2007 Mar; 14(3):1051-7. PubMed ID: 17206485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.